GoodRx Holdings (GDRX) Total Liabilities (2019 - 2026)

GoodRx Holdings has disclosed Total Liabilities across 8 years of filings, most recently posting $1.4 billion for Q1 2026.

• Total Liabilities for Q1 2026 came in at $1.4 billion, up 118.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 118.32% YoY), and the FY2025 annual result was $787.8 million, up 18.75% from the prior year.
• Total Liabilities came in at $1.4 billion for Q1 2026 at GoodRx Holdings, up from $787.8 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.4 billion in Q1 2026 to a low of $640.9 million in Q1 2025.
• The 5-year median for Total Liabilities is $784.0 million (2023), against an average of $794.6 million.
• Across the five-year window, Total Liabilities slipped 22.11% in 2025 and soared 118.32% in 2026, its largest moves.
• GoodRx Holdings' Total Liabilities stood at $789.8 million in 2022, then increased by 4.69% to $826.8 million in 2023, then slipped by 19.77% to $663.4 million in 2024, then grew by 18.75% to $787.8 million in 2025, then soared by 77.62% to $1.4 billion in 2026.
• The last three Total Liabilities figures came in at $1.4 billion (Q1 2026), $787.8 million (Q4 2025), and $724.8 million (Q3 2025), per Business Quant data.